CompletedPhase 2

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

NCT02067793

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Pacific Research Partners

Oakland, California, United States

+11 additional locations

Save this trial

Pacific Research PartnersOakland, California, United States
Psychiatric Medicine AssociatesSkokie, Illinois, United States
University of Kansas School of Medicine Clinical Trial UnitWichita, Kansas, United States
Boston Clinical Trials, Inc.Roslindale, Massachusetts, United States
Psychiatric Care and Research CenterO'Fallon, Missouri, United States
Mount Sinai School of MedicineElmsford, New York, United States
New York State Psychiatric InstituteNew York, New York, United States
Lindner Center of HOPEMason, Ohio, United States
Research Strategies MemphisMemphis, Tennessee, United States
Research Across AmericaDallas, Texas, United States
Lifetree Clinical ResearchSalt Lake City, Utah, United States
Psychiatric Alliance of the Blue RidgeCharlottesville, Virginia, United States